Lanean...
Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study
BACKGROUND: Palmitoylethanolamide (PEA) is emerging as a new therapeutic approach in pain and inflammatory conditions, and it has been evaluated in studies on various painful diseases. The aim of this open-label study was to evaluate the efficacy of ultramicronized PEA (umPEA) in the prophylactic tr...
Gorde:
| Argitaratua izan da: | Pain Res Manag |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7196162/ https://ncbi.nlm.nih.gov/pubmed/32377286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3938640 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|